Current Edition

booster

After FDA green lights a second COVID booster, official says another could come in the fall

A few hours after the FDA authorized a fourth dose of the Moderna and Pfizer-BioNTech COVID-19 vaccines, one of its top experts hinted that a …

Continue Reading →
COVID-19

Johnson & Johnson wins FDA panel backing for a second dose of its COVID shot but don’t call it a ‘booster’

Over the last year, the Johnson & Johnson COVID-19 vaccine has been commonly referred to as a single-shot alternative to the two-dose regimens of mRNA …

Continue Reading →
COVID-19

Pfizer, Moderna will rake in a combined $93 billion next year on COVID-19 vaccine sales

If you think Pfizer-BioNTech and Moderna are making a fortune on COVID-19 vaccine sales this year, just wait for 2022. The messenger RNA shot producers …

Continue Reading →
Federal Trade Commission

Sanofi refiles $3.2B Translate Bio buyout with FTC to allow more time for review

Ever since the Federal Trade Commission (FTC) unveiled its campaign to take a closer look at biopharma’s M&A strategies, the industry’s dealmakers have been on …

Continue Reading →